{"id":"https://openalex.org/W1483839142","doi":"https://doi.org/10.1002/cncr.26372","title":"Cost\u2010effectiveness of epidermal growth factor receptor mutation testing and first\u2010line treatment with gefitinib for patients with advanced adenocarcinoma of the lung","display_name":"Cost\u2010effectiveness of epidermal growth factor receptor mutation testing and first\u2010line treatment with gefitinib for patients with advanced adenocarcinoma of the lung","publication_year":2011,"publication_date":"2011-07-26","ids":{"openalex":"https://openalex.org/W1483839142","doi":"https://doi.org/10.1002/cncr.26372","mag":"1483839142","pmid":"https://pubmed.ncbi.nlm.nih.gov/21792863"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.26372","doi":"https://doi.org/10.1002/cncr.26372","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.26372","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.26372","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.26372","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068401391","display_name":"Gilberto De Lima Lopes Jr.","orcid":"https://orcid.org/0000-0002-1151-9903","observed_orcids":["https://orcid.org/0000-0002-1151-9903"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gilberto de Lima Lopes","raw_affiliation_strings":["Johns Hopkins Singapore International Medical Centre, Singapore, Republic of Singapore. glopes@imc.jhmi.edu","Johns Hopkins Singapore International Medical Centre, Singapore, Republic of Singapore","Johns Hopkins University School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins Singapore International Medical Centre, Singapore, Republic of Singapore. glopes@imc.jhmi.edu","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Johns Hopkins Singapore International Medical Centre, Singapore, Republic of Singapore","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044279206","display_name":"Joel E. Segel","orcid":"https://orcid.org/0000-0001-8937-0531","observed_orcids":["https://orcid.org/0000-0001-8937-0531"]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]},{"id":"https://openalex.org/I4210126319","display_name":"Duke-NUS Medical School","ror":"https://ror.org/02j1m6098","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596","https://openalex.org/I170897317","https://openalex.org/I4210126319"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Joel E. Segel","raw_affiliation_strings":["Duke-National University of Singapore Health Systems and Services Research Program, Singapore, Republic of Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke-National University of Singapore Health Systems and Services Research Program, Singapore, Republic of Singapore","institution_ids":["https://openalex.org/I165932596","https://openalex.org/I4210126319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063823247","display_name":"Daniel S.W. Tan","orcid":"https://orcid.org/0000-0002-6514-6786","observed_orcids":["https://orcid.org/0000-0002-6514-6786"]},"institutions":[{"id":"https://openalex.org/I4210137145","display_name":"National Cancer Centre Singapore","ror":"https://ror.org/03bqk3e80","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I4210137145"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Daniel S. W. Tan","raw_affiliation_strings":["National Cancer Centre, Singapore, Republic of Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Centre, Singapore, Republic of Singapore","institution_ids":["https://openalex.org/I4210137145"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Young K. Do","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]},{"id":"https://openalex.org/I4210126319","display_name":"Duke-NUS Medical School","ror":"https://ror.org/02j1m6098","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596","https://openalex.org/I170897317","https://openalex.org/I4210126319"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Young K. Do","raw_affiliation_strings":["Duke-National University of Singapore Health Systems and Services Research Program, Singapore, Republic of Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke-National University of Singapore Health Systems and Services Research Program, Singapore, Republic of Singapore","institution_ids":["https://openalex.org/I165932596","https://openalex.org/I4210126319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066717752","display_name":"Tony S.K. Mok","orcid":"https://orcid.org/0000-0002-8251-0551","observed_orcids":["https://orcid.org/0000-0002-8251-0551"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Tony Mok","raw_affiliation_strings":["Chinese University of Hong Kong, Shatin, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chinese University of Hong Kong, Shatin, Hong Kong, China","institution_ids":["https://openalex.org/I177725633"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042922076","display_name":"Eric Andrew Finkelstein","orcid":"https://orcid.org/0000-0001-6443-9686","observed_orcids":["https://orcid.org/0000-0001-6443-9686"]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]},{"id":"https://openalex.org/I4210126319","display_name":"Duke-NUS Medical School","ror":"https://ror.org/02j1m6098","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596","https://openalex.org/I170897317","https://openalex.org/I4210126319"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Eric A. Finkelstein","raw_affiliation_strings":["Duke-National University of Singapore Health Systems and Services Research Program, Singapore, Republic of Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke-National University of Singapore Health Systems and Services Research Program, Singapore, Republic of Singapore","institution_ids":["https://openalex.org/I165932596","https://openalex.org/I4210126319"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5068401391"],"corresponding_institution_ids":["https://openalex.org/I145311948"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":22.6624,"has_fulltext":true,"cited_by_count":64,"citation_normalized_percentile":{"value":0.99230053,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"118","issue":"4","first_page":"1032","last_page":"1039"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.6859999895095825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.6859999895095825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.30880001187324524,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8109999895095825},{"id":"https://openalex.org/keywords/egfr-mutation-testing","display_name":"EGFR mutation testing","score":0.8999999761581421},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/advanced-lung-adenocarcinoma","display_name":"advanced lung adenocarcinoma","score":0.8769999742507935},{"id":"https://openalex.org/keywords/egfr-activating-mutations","display_name":"EGFR activating mutations","score":0.8410000205039978},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7739999890327454},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7250000238418579},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.4749999940395355},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9760000109672546},{"id":"https://openalex.org/keywords/decision-analytic-model","display_name":"decision-analytic model","score":0.8619999885559082},{"id":"https://openalex.org/keywords/singapore","display_name":"Singapore","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.9726064205169678},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8188374042510986},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6707123517990112},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.5915179252624512},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5907584428787231},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.548770546913147},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.529365062713623},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.48935550451278687},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46431824564933777},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4255809783935547},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42317235469818115},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4158391058444977},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2930845022201538},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.08903971314430237},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068437","descriptor_name":"Pemetrexed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077192","descriptor_name":"Adenocarcinoma of Lung","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005820","descriptor_name":"Genetic Testing","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D010597","descriptor_name":"Pharmacogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012846","descriptor_name":"Singapore","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/cncr.26372","doi":"https://doi.org/10.1002/cncr.26372","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.26372","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.26372","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:21792863","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21792863","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Journal Article"},{"id":"pmh:oai:scholarbank.nus.edu.sg:10635/124662","doi":null,"is_oa":false,"landing_page_url":"http://scholarbank.nus.edu.sg/handle/10635/124662","pdf_url":null,"source":{"id":"https://openalex.org/S7407052290","display_name":"National University of Singapore","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scopus","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1002/cncr.26372","doi":"https://doi.org/10.1002/cncr.26372","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.26372","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.26372","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1483839142.pdf","grobid_xml":"https://content.openalex.org/works/W1483839142.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W2052335855","https://openalex.org/W2064224599","https://openalex.org/W2083336755","https://openalex.org/W2100912832","https://openalex.org/W2105026490","https://openalex.org/W2120718661","https://openalex.org/W2122553809","https://openalex.org/W2123683855","https://openalex.org/W2128473443","https://openalex.org/W2129360604","https://openalex.org/W2132157071","https://openalex.org/W2138297714","https://openalex.org/W2146404049","https://openalex.org/W2153477391","https://openalex.org/W2166084034","https://openalex.org/W2171981784","https://openalex.org/W2217379577","https://openalex.org/W2270409815","https://openalex.org/W2341301791","https://openalex.org/W2581835979","https://openalex.org/W2625768146","https://openalex.org/W2626223149"],"related_works":["https://openalex.org/W2018832622","https://openalex.org/W2563308044","https://openalex.org/W1808281120","https://openalex.org/W2156145594","https://openalex.org/W2133211848","https://openalex.org/W4404655662","https://openalex.org/W1273305858","https://openalex.org/W2486101759","https://openalex.org/W2010515258","https://openalex.org/W3210086490"],"abstract_inverted_index":{"BACKGROUND:":[0],"Epidermal":[1],"growth":[2],"factor":[3],"receptor":[4],"(EGFR)":[5],"testing":[6,54,127],"and":[7,55,86,93,109,119,128,140,207,217,232],"first-line":[8,56,72,129,178,188],"therapy":[9],"with":[10,14,58,74,131,144,180,187,192,240],"gefitinib":[11,59,78,132,155,181],"for":[12,23,60,213],"patients":[13,62,191],"activating":[15,65,172,193],"mutations":[16,66],"is":[17,34,133,228],"quickly":[18],"becoming":[19],"the":[20,24,37,50,148,169],"standard":[21,68,145,204],"option":[22],"treatment":[25,57,73,130,179],"of":[26,39,52,168,171,205,210],"advanced":[27],"lung":[28],"adenocarcinoma.":[29],"Yet,":[30],"to":[31,48,156,162,229],"date,":[32],"little":[33],"known":[35],"about":[36],"cost-effectiveness":[38,51,110],"this":[40,164],"approach.":[41],"METHODS:":[42],"A":[43],"decision-analytic":[44],"model":[45,83],"was":[46,182],"developed":[47],"determine":[49],"EGFR":[53,126,194],"those":[61,157],"who":[63,158],"harbor":[64],"versus":[67],"care,":[69],"which":[70,224],"includes":[71],"chemotherapy":[75,189],"followed":[76],"by":[77],"as":[79,104],"second-line":[80],"treatment.":[81],"The":[82],"uses":[84],"clinical":[85,91],"outcomes":[87,239],"data":[88],"from":[89,96,152],"randomized":[90],"trials":[92],"societal":[94],"costs":[95,108,139],"Singapore":[97,116],"cancer":[98],"centers.":[99],"Health":[100],"effects":[101],"were":[102,112,123],"expressed":[103,113],"quality-adjusted":[105],"life-years.":[106],"All":[107],"ratios":[111],"in":[114,190,220,223,237],"2010":[115],"dollars.":[117],"Sensitivity":[118],"different":[120],"scenarios":[121],"analyses":[122],"conducted.":[124],"RESULTS:":[125],"a":[134,175,202],"dominant":[135,184],"strategy":[136,198],"(with":[137],"lower":[138],"greater":[141],"effectiveness)":[142],"compared":[143,186],"care.":[146],"Because":[147],"primary":[149],"savings":[150],"result":[151],"not":[153,160],"providing":[154],"are":[159],"likely":[161],"benefit,":[163],"finding":[165],"holds":[166],"regardless":[167],"prevalence":[170],"mutations.":[173,195],"In":[174],"secondary":[176],"analysis,":[177],"also":[183],"when":[185],"CONCLUSIONS:":[196],"This":[197],"can":[199],"be":[200,209],"considered":[201],"new":[203],"care":[206,215],"should":[208],"great":[211],"interest":[212],"health":[214],"payers":[216],"decision":[218],"makers":[219],"an":[221],"era":[222],"our":[225],"greatest":[226],"challenge":[227],"balance":[230],"hard-won":[231],"incremental,":[233],"yet":[234],"small,":[235],"improvements":[236],"patient":[238],"exponentially":[241],"rising":[242],"costs.":[243]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":12}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}